Parallel Bio
Using the immune system to cure disease
Parallel Bio is pioneering human-first drug discovery by creating the first map of human biology. Using groundbreaking biological and computational tools that track real clinical outcomes, the company generates data that enable earlier, more reliable decisions about disease biology and drug development. Parallel Bio’s platform overcomes the core limitations of traditional animal testing, which fails to encapsulate the complexity of human biology. The company is building internal pipelines of novel disease targets and drug candidates in both cancer and autoimmune disease, while collaborating with pharmaceutical companies to evaluate therapies directly in human systems to reduce the cost and risk of clinical trials. Based in San Francisco, the company was founded in 2021 by two of the world’s leading experts in replacing animal models with human-first platforms.
- Website
- parallel.bio
- City
- San Francisco
- Country
- United States
- YC batch
- Summer 2021
- Team
- 20 people
- Stage
- Early stage
- AI-native
- No
- Hiring
- Open roles
More Health & bio in San Francisco
Innovaccer$1.3bn
Indian digital healthcare company.
Thatch$1bn
Health benefits. Valued at $1bn (September 2026).
Chan Zuckerberg BiohubLab
Nonprofit research network building virtual cell models.
AthelasHiring
Extensible, Integrated Technology that Simplifies Health Systems
ClipboardHiring
Every shift, Covered.
Benchling
Unlocking the power of biotech with modern software for modern science
Claim this profile
Free and instant: prove you run parallel.bio and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Parallel Bio across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Parallel Bio's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
